BeiGene (BGNE) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free BGNE Stock Alerts $155.08 +1.27 (+0.83%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BeiGene Short Interest DataCurrent Short Volume1,730,000 sharesPrevious Short Volume1,930,000 sharesChange Vs. Previous Month-10.36%Dollar Volume Sold Short$294.10 millionShort Interest Ratio / Days to Cover5.9Last Record DateMarch 15, 2024Outstanding Shares95,580,000 sharesPercentage of Shares Shorted1.81%Today's Trading Volume76,133 sharesAverage Trading Volume286,372 sharesToday's Volume Vs. Average27% Short Selling BeiGene ? Sign up to receive the latest short interest report for BeiGene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBGNE Short Interest Over TimeBGNE Days to Cover Over TimeBGNE Percentage of Float Shorted Over Time Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. BeiGene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20241,730,000 shares $294.10 million -10.4%N/A5.9 $170.00 2/29/20241,930,000 shares $319.70 million +10.3%N/A6.6 $165.65 2/15/20241,750,000 shares $255.62 million -15.9%N/A6.2 $146.07 1/31/20242,080,000 shares $308.32 million -2.4%N/A7.4 $148.23 1/15/20242,130,000 shares $373.20 million +16.4%N/A8.3 $175.21 12/31/20231,830,000 shares $330.06 million +20.4%N/A7.5 $180.36 Get the Latest News and Ratings for BGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BeiGene and its competitors with MarketBeat's FREE daily newsletter. 12/15/20231,520,000 shares $278.27 million +26.7%N/A6.8 $183.07 11/30/20231,200,000 shares $224.33 million -18.9%N/A5.6 $186.94 11/15/20231,480,000 shares $290.88 million +23.3%N/A6.9 $196.54 10/31/20231,200,000 shares $223.54 million -28.6%N/A5.7 $186.28 10/15/20231,680,000 shares $300.37 million +1.2%N/A7.5 $178.79 9/30/20231,660,000 shares $298.58 million No ChangeN/A7.7 $179.87 9/15/20231,660,000 shares $332.53 million No ChangeN/A7.4 $200.32 8/31/20231,660,000 shares $344.53 million -4.1%N/A6.8 $207.55 8/15/20231,730,000 shares $350.71 million +7.5%N/A7.2 $202.72 7/31/20231,610,000 shares $344.89 million -10.1%N/A7 $214.22 7/15/20231,790,000 shares $351.43 million -2.7%N/A8.6 $196.33 6/30/20231,840,000 shares $328.07 million +1.1%N/A8.5 $178.30 6/15/20231,820,000 shares $365.89 million -1.1%N/A8.4 $201.04 5/31/20231,840,000 shares $406.51 million -2.7%N/A9.5 $220.93 5/15/20231,890,000 shares $454.07 million -9.1%N/A9.4 $240.25 4/30/20232,080,000 shares $530.32 million -4.6%N/A9.9 $254.96 4/15/20232,180,000 shares $575.52 million +1.4%N/A9.9 $264.00 3/31/20232,150,000 shares $463.39 million -1.4%N/A9 $215.53 3/15/20232,180,000 shares $514.37 million +7.9%N/A8.9 $235.95 2/28/20232,020,000 shares $453.75 million +4.1%N/A8 $224.63 2/15/20231,940,000 shares $463.18 million -0.5%N/A7.2 $238.75 1/31/20231,950,000 shares $499.20 million +1.6%N/A7.1 $256.00 1/15/20231,920,000 shares $519.67 million -6.3%N/A7.1 $270.66 12/30/20222,050,000 shares $450.88 million +2.0%N/A7.3 $219.94 12/15/20222,010,000 shares $417.92 million +2.0%N/A7.2 $207.92 11/30/20221,970,000 shares $377.47 million -4.8%N/A7.4 $191.61 11/15/20222,070,000 shares $429.96 million -3.7%N/A8.7 $207.71 10/31/20222,150,000 shares $363.11 million +7.5%N/A9.3 $168.89 10/15/20222,000,000 shares $311.68 million -12.7%N/A8.4 $155.84 9/30/20222,290,000 shares $308.74 million +13.9%N/A10.7 $134.82 9/15/20222,010,000 shares $322.87 million +3.1%N/A8.4 $160.63 8/31/20221,950,000 shares $334.74 million -7.1%N/A7.7 $171.66 8/15/20222,100,000 shares $414.04 million -7.9%N/A7.9 $197.16 7/31/20222,280,000 shares $383.22 million +3.6%N/A7.6 $168.08Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… BGNE Short Interest - Frequently Asked Questions What is BeiGene's current short interest? Short interest is the volume of BeiGene shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 1,730,000 shares of BGNE short. Learn More on BeiGene's current short interest. What is a good short interest ratio for BeiGene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BGNE shares currently have a short interest ratio of 6.0. Learn More on BeiGene's short interest ratio. Which institutional investors are shorting BeiGene? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BeiGene: Barclays PLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BeiGene's short interest increasing or decreasing? BeiGene saw a decrease in short interest in March. As of March 15th, there was short interest totaling 1,730,000 shares, a decrease of 10.4% from the previous total of 1,930,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BeiGene's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BeiGene: Viatris Inc. (3.32%), Teva Pharmaceutical Industries Limited (0.93%), BioMarin Pharmaceutical Inc. (1.57%), Karuna Therapeutics, Inc. (5.16%), Dr. Reddy's Laboratories Limited (0.43%), Sarepta Therapeutics, Inc. (5.29%), United Therapeutics Co. (4.43%), Alnylam Pharmaceuticals, Inc. (2.14%), Catalent, Inc. (4.34%), Legend Biotech Co. (6.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short BeiGene stock? Short selling BGNE is an investing strategy that aims to generate trading profit from BeiGene as its price is falling. BGNE shares are trading up $1.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BeiGene? A short squeeze for BeiGene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BGNE, which in turn drives the price of the stock up even further. How often is BeiGene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGNE, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VTRS Short Interest TEVA Short Interest BMRN Short Interest KRTX Short Interest RDY Short Interest SRPT Short Interest UTHR Short Interest ALNY Short Interest CTLT Short Interest LEGN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BGNE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings